Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Zero based budgeting tips for families of 5 or more focus on scalable categories, collaborative planning, and routine check-ins to maintain control.
27,578 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Chip stocks slipped as SK Hynix flagged weaker memory demand and a jump in oil prices threatened chip margins. The tr...
If you’re nearing retirement, it’s smart to pause and assess. Here are five telltale signs you might want to wait, pl...
The ROAD Act was billed as a catalyst for more homes, but builders, lenders, and markets show a tepid path forward as...
A 54-year-old former corporate worker considers a welding certificate in shipbuilding after a layoff. The move could ...
What to watch as J.B. Hunt moves into 2026. This analysis breaks down the Q2 dynamics, segment performance, and what ...
Traders are shifting toward a data-driven approach to forex analysis as policy shifts and macro data reshape currency...
A bank ETF can be a reliable engine for a value-focused portfolio, capturing the cash-generating power of U.S. lender...
Looking for a few durable holdings to anchor a decades-long portfolio? Here are three monster stocks hold next—giants...
As volatility rattles markets in early 2026, retirees are turning to a trio of low-volatility ETFs that blend income ...
Tempus AI is set to report quarterly earnings after the close, with investors watching for growth signals and profita...
The latest Freddie Mac survey shows the 30-year fixed rate dipping under 6% for the first time in years, signaling po...